Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26 entities : Sanofi save search
BioMarin Announces Third Quarter 2022 Year-over-Year Total Revenue Growth of 24% (31% Excluding KUVAN®)
Published: 2022-10-26 (Crawled : 20:00) - investors.biomarin.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -2.68%
H: 0.0%
C: -4.35%
kuvan growth
The Global Medical Exoskeletons Market to Register Positive Growth at a Significant CAGR of 18.23% by 2027 | DelveInsight
Published: 2022-10-26 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
NVRO | $12.07 -2.03% 0.0% 390K
|
Health Technology
|
| O: -1.43%
H: 0.0%
C: -4.66%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.46%
H: 2.07%
C: 0.57%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 1.6%
H: 1.72%
C: -0.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
global positive growth market
Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-26 (Crawled : 12:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
AHPA 4 | $6.125 -9.26% 4.33%
|
|
| O: -5.1%
H: 1.72%
C: -8.48%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
treatment fda approval
BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya® Smart Sensor BIOCORP announces the signature of a partnership agreement with Novo Nordisk for the commercialization...
Published: 2022-10-26 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
PCVX | $60.82 0.33% 0.33% 1.3M
|
Health Technology
|
| O: 2.12%
H: 18.76%
C: 14.61%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
mallya partnership sensor smart agreement
Dassault Systèmes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future “EVolutive Facilities”
Published: 2022-10-26 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
transfer sanofi
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.